Feedback / Questions
Temferon (Autologous CD34+ enriched HSPCs expressing interferon-alpha 2) - Genenta Science
https://www.globenewswire.com/news-release/2025/07/01/3108119/0/en/Genenta-Announces-Long-Term-Follow-Up-Observations-in-Brain-Tumor-GBM-Study-with-Emerging-Survival-Signals.html
Jul 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next